0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global High-Throughput Screening Services for Drug Discovery Market Research Report 2026
Published Date: 2026-03-30
|
Report Code: QYRE-Auto-8L17549
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global High Throughput Screening Services for Drug Discovery Market Research Report 2024
BUY CHAPTERS

Global High-Throughput Screening Services for Drug Discovery Market Research Report 2026

Code: QYRE-Auto-8L17549
Report
2026-03-30
Pages:138
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

High-Throughput Screening Services for Drug Discovery Market

The global High-Throughput Screening Services for Drug Discovery market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
To carry out high-throughput screening experiments, facilities often employ automated instruments and liquid handlers in order to test many samples quickly and efficiently. High-throughput screening (HTS) services offer researchers easy access to the experience, expertise, and instrumentation needed to conduct a variety of assays to advance processes in drug discovery and development. HTS applications include enzyme activity assays, molecular binding assays, protein-protein interactions, gene expression screening, compound library screening, cell-based assays, and GPCR assays. HTS-based services often can be tailored to customized requests and the unique requirements of the project. Service providers can also provide technical and scientific advice from the early stages of the project to completion and data analysis.
The North American market for High-Throughput Screening Services for Drug Discovery is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The Asia-Pacific market for High-Throughput Screening Services for Drug Discovery is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.
The global market for High-Throughput Screening Services for Drug Discovery in Pharmaceutical Company is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.
Major global companies of High-Throughput Screening Services for Drug Discovery include Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.
This report delivers a comprehensive overview of the global High-Throughput Screening Services for Drug Discovery market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding High-Throughput Screening Services for Drug Discovery. The High-Throughput Screening Services for Drug Discovery market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global High-Throughput Screening Services for Drug Discovery market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist High-Throughput Screening Services for Drug Discovery manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of High-Throughput Screening Services for Drug Discovery Market Report

Report Metric Details
Report Name High-Throughput Screening Services for Drug Discovery Market
Segment by Type
  • Chemical-based HTS Assays
  • Biological-based HTS Assays
  • Cell-based HTS Assays
  • Genetic-based HTS Assays
Segment by Application
  • Pharmaceutical Company
  • Biotechnology Company
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, Creative Biolabs, Creative Bioarray, BOC Sciences, MEDICILON, Domainex, Creative Diagnostics, Multispan, AntalGenics, Creative Biostructure, BPS Bioscience
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
  • Chapter 3: Provides a detailed view of the competitive landscape for High-Throughput Screening Services for Drug Discovery companies, covering revenue share, development plans, and mergers and acquisitions.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
  • Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
  • Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
  • Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
  • Chapter 12: Key findings and conclusions of the report.

FAQ for this report

Who are the main players in the High-Throughput Screening Services for Drug Discovery Market report?

Ans: The main players in the High-Throughput Screening Services for Drug Discovery Market are Eurofins Discovery, Charles River Laboratories, Axcelead, NUVISAN, Axxam S.p.A., Evotec, Selvita, Azenta Life Sciences, Bienta (Enamine), Cayman Chemical, Creative Biolabs, Creative Bioarray, BOC Sciences, MEDICILON, Domainex, Creative Diagnostics, Multispan, AntalGenics, Creative Biostructure, BPS Bioscience

What are the Application segmentation covered in the High-Throughput Screening Services for Drug Discovery Market report?

Ans: The Applications covered in the High-Throughput Screening Services for Drug Discovery Market report are Pharmaceutical Company, Biotechnology Company

What are the Type segmentation covered in the High-Throughput Screening Services for Drug Discovery Market report?

Ans: The Types covered in the High-Throughput Screening Services for Drug Discovery Market report are Chemical-based HTS Assays, Biological-based HTS Assays, Cell-based HTS Assays, Genetic-based HTS Assays

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Chemical-based HTS Assays
1.2.3 Biological-based HTS Assays
1.2.4 Cell-based HTS Assays
1.2.5 Genetic-based HTS Assays
1.3 Market by Application
1.3.1 Global High-Throughput Screening Services for Drug Discovery Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical Company
1.3.3 Biotechnology Company
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global High-Throughput Screening Services for Drug Discovery Market Perspective (2021–2032)
2.2 Global High-Throughput Screening Services for Drug Discovery Growth Trends by Region
2.2.1 Global High-Throughput Screening Services for Drug Discovery Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 High-Throughput Screening Services for Drug Discovery Historic Market Size by Region (2021–2026)
2.2.3 High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Region (2027–2032)
2.3 High-Throughput Screening Services for Drug Discovery Market Dynamics
2.3.1 High-Throughput Screening Services for Drug Discovery Industry Trends
2.3.2 High-Throughput Screening Services for Drug Discovery Market Drivers
2.3.3 High-Throughput Screening Services for Drug Discovery Market Challenges
2.3.4 High-Throughput Screening Services for Drug Discovery Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top High-Throughput Screening Services for Drug Discovery Players by Revenue
3.1.1 Global Top High-Throughput Screening Services for Drug Discovery Players by Revenue (2021–2026)
3.1.2 Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Players (2021–2026)
3.2 Global Top High-Throughput Screening Services for Drug Discovery Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by High-Throughput Screening Services for Drug Discovery Revenue
3.4 Global High-Throughput Screening Services for Drug Discovery Market Concentration Ratio
3.4.1 Global High-Throughput Screening Services for Drug Discovery Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by High-Throughput Screening Services for Drug Discovery Revenue in 2025
3.5 Global Key Players of High-Throughput Screening Services for Drug Discovery Head Offices and Areas Served
3.6 Global Key Players of High-Throughput Screening Services for Drug Discovery, Products and Applications
3.7 Global Key Players of High-Throughput Screening Services for Drug Discovery, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 High-Throughput Screening Services for Drug Discovery Breakdown Data by Type
4.1 Global High-Throughput Screening Services for Drug Discovery Historic Market Size by Type (2021–2026)
4.2 Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Type (2027–2032)
5 High-Throughput Screening Services for Drug Discovery Breakdown Data by Application
5.1 Global High-Throughput Screening Services for Drug Discovery Historic Market Size by Application (2021–2026)
5.2 Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
6.2 North America High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
6.4 North America High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
7.2 Europe High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
7.4 Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
8.2 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (2021–2026)
8.4 Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
9.2 Latin America High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
9.4 Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size (2021–2032)
10.2 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (2021–2026)
10.4 Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Eurofins Discovery
11.1.1 Eurofins Discovery Company Details
11.1.2 Eurofins Discovery Business Overview
11.1.3 Eurofins Discovery High-Throughput Screening Services for Drug Discovery Introduction
11.1.4 Eurofins Discovery Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.1.5 Eurofins Discovery Recent Development
11.2 Charles River Laboratories
11.2.1 Charles River Laboratories Company Details
11.2.2 Charles River Laboratories Business Overview
11.2.3 Charles River Laboratories High-Throughput Screening Services for Drug Discovery Introduction
11.2.4 Charles River Laboratories Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.2.5 Charles River Laboratories Recent Development
11.3 Axcelead
11.3.1 Axcelead Company Details
11.3.2 Axcelead Business Overview
11.3.3 Axcelead High-Throughput Screening Services for Drug Discovery Introduction
11.3.4 Axcelead Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.3.5 Axcelead Recent Development
11.4 NUVISAN
11.4.1 NUVISAN Company Details
11.4.2 NUVISAN Business Overview
11.4.3 NUVISAN High-Throughput Screening Services for Drug Discovery Introduction
11.4.4 NUVISAN Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.4.5 NUVISAN Recent Development
11.5 Axxam S.p.A.
11.5.1 Axxam S.p.A. Company Details
11.5.2 Axxam S.p.A. Business Overview
11.5.3 Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Introduction
11.5.4 Axxam S.p.A. Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.5.5 Axxam S.p.A. Recent Development
11.6 Evotec
11.6.1 Evotec Company Details
11.6.2 Evotec Business Overview
11.6.3 Evotec High-Throughput Screening Services for Drug Discovery Introduction
11.6.4 Evotec Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.6.5 Evotec Recent Development
11.7 Selvita
11.7.1 Selvita Company Details
11.7.2 Selvita Business Overview
11.7.3 Selvita High-Throughput Screening Services for Drug Discovery Introduction
11.7.4 Selvita Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.7.5 Selvita Recent Development
11.8 Azenta Life Sciences
11.8.1 Azenta Life Sciences Company Details
11.8.2 Azenta Life Sciences Business Overview
11.8.3 Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Introduction
11.8.4 Azenta Life Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.8.5 Azenta Life Sciences Recent Development
11.9 Bienta (Enamine)
11.9.1 Bienta (Enamine) Company Details
11.9.2 Bienta (Enamine) Business Overview
11.9.3 Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Introduction
11.9.4 Bienta (Enamine) Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.9.5 Bienta (Enamine) Recent Development
11.10 Cayman Chemical
11.10.1 Cayman Chemical Company Details
11.10.2 Cayman Chemical Business Overview
11.10.3 Cayman Chemical High-Throughput Screening Services for Drug Discovery Introduction
11.10.4 Cayman Chemical Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.10.5 Cayman Chemical Recent Development
11.11 Creative Biolabs
11.11.1 Creative Biolabs Company Details
11.11.2 Creative Biolabs Business Overview
11.11.3 Creative Biolabs High-Throughput Screening Services for Drug Discovery Introduction
11.11.4 Creative Biolabs Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.11.5 Creative Biolabs Recent Development
11.12 Creative Bioarray
11.12.1 Creative Bioarray Company Details
11.12.2 Creative Bioarray Business Overview
11.12.3 Creative Bioarray High-Throughput Screening Services for Drug Discovery Introduction
11.12.4 Creative Bioarray Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.12.5 Creative Bioarray Recent Development
11.13 BOC Sciences
11.13.1 BOC Sciences Company Details
11.13.2 BOC Sciences Business Overview
11.13.3 BOC Sciences High-Throughput Screening Services for Drug Discovery Introduction
11.13.4 BOC Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.13.5 BOC Sciences Recent Development
11.14 MEDICILON
11.14.1 MEDICILON Company Details
11.14.2 MEDICILON Business Overview
11.14.3 MEDICILON High-Throughput Screening Services for Drug Discovery Introduction
11.14.4 MEDICILON Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.14.5 MEDICILON Recent Development
11.15 Domainex
11.15.1 Domainex Company Details
11.15.2 Domainex Business Overview
11.15.3 Domainex High-Throughput Screening Services for Drug Discovery Introduction
11.15.4 Domainex Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.15.5 Domainex Recent Development
11.16 Creative Diagnostics
11.16.1 Creative Diagnostics Company Details
11.16.2 Creative Diagnostics Business Overview
11.16.3 Creative Diagnostics High-Throughput Screening Services for Drug Discovery Introduction
11.16.4 Creative Diagnostics Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.16.5 Creative Diagnostics Recent Development
11.17 Multispan
11.17.1 Multispan Company Details
11.17.2 Multispan Business Overview
11.17.3 Multispan High-Throughput Screening Services for Drug Discovery Introduction
11.17.4 Multispan Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.17.5 Multispan Recent Development
11.18 AntalGenics
11.18.1 AntalGenics Company Details
11.18.2 AntalGenics Business Overview
11.18.3 AntalGenics High-Throughput Screening Services for Drug Discovery Introduction
11.18.4 AntalGenics Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.18.5 AntalGenics Recent Development
11.19 Creative Biostructure
11.19.1 Creative Biostructure Company Details
11.19.2 Creative Biostructure Business Overview
11.19.3 Creative Biostructure High-Throughput Screening Services for Drug Discovery Introduction
11.19.4 Creative Biostructure Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.19.5 Creative Biostructure Recent Development
11.20 BPS Bioscience
11.20.1 BPS Bioscience Company Details
11.20.2 BPS Bioscience Business Overview
11.20.3 BPS Bioscience High-Throughput Screening Services for Drug Discovery Introduction
11.20.4 BPS Bioscience Revenue in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
11.20.5 BPS Bioscience Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
 Table 2. Key Players of Chemical-based HTS Assays
 Table 3. Key Players of Biological-based HTS Assays
 Table 4. Key Players of Cell-based HTS Assays
 Table 5. Key Players of Genetic-based HTS Assays
 Table 6. Global High-Throughput Screening Services for Drug Discovery Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
 Table 7. Global High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 8. Global High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million), 2021–2026
 Table 9. Global High-Throughput Screening Services for Drug Discovery Market Share by Region (2021–2026)
 Table 10. Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Region (US$ Million), 2027–2032
 Table 11. Global High-Throughput Screening Services for Drug Discovery Market Share by Region (2027–2032)
 Table 12. High-Throughput Screening Services for Drug Discovery Market Trends
 Table 13. High-Throughput Screening Services for Drug Discovery Market Drivers
 Table 14. High-Throughput Screening Services for Drug Discovery Market Challenges
 Table 15. High-Throughput Screening Services for Drug Discovery Market Restraints
 Table 16. Global High-Throughput Screening Services for Drug Discovery Revenue by Players (US$ Million), 2021–2026
 Table 17. Global High-Throughput Screening Services for Drug Discovery Market Share by Players (2021–2026)
 Table 18. Global Top High-Throughput Screening Services for Drug Discovery Players by Tier (Tier 1, Tier 2, and Tier 3), based on High-Throughput Screening Services for Drug Discovery Revenue, 2025
 Table 19. Ranking of Global Top High-Throughput Screening Services for Drug Discovery Companies by Revenue (US$ Million) in 2025
 Table 20. Global 5 Largest Players Market Share by High-Throughput Screening Services for Drug Discovery Revenue (CR5 and HHI), 2021–2026
 Table 21. Global Key Players of High-Throughput Screening Services for Drug Discovery, Headquarters and Area Served
 Table 22. Global Key Players of High-Throughput Screening Services for Drug Discovery, Products and Applications
 Table 23. Global Key Players of High-Throughput Screening Services for Drug Discovery, Date of General Availability (GA)
 Table 24. Mergers and Acquisitions, Expansion Plans
 Table 25. Global High-Throughput Screening Services for Drug Discovery Market Size by Type (US$ Million), 2021–2026
 Table 26. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Type (2021–2026)
 Table 27. Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Type (US$ Million), 2027–2032
 Table 28. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Type (2027–2032)
 Table 29. Global High-Throughput Screening Services for Drug Discovery Market Size by Application (US$ Million), 2021–2026
 Table 30. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Application (2021–2026)
 Table 31. Global High-Throughput Screening Services for Drug Discovery Forecasted Market Size by Application (US$ Million), 2027–2032
 Table 32. Global High-Throughput Screening Services for Drug Discovery Revenue Market Share by Application (2027–2032)
 Table 33. North America High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 34. North America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 35. North America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 36. Europe High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 37. Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 38. Europe High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 39. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 40. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million), 2021–2026
 Table 41. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size by Region (US$ Million), 2027–2032
 Table 42. Latin America High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 43. Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 44. Latin America High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 45. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
 Table 46. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2021–2026
 Table 47. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size by Country (US$ Million), 2027–2032
 Table 48. Eurofins Discovery Company Details
 Table 49. Eurofins Discovery Business Overview
 Table 50. Eurofins Discovery High-Throughput Screening Services for Drug Discovery Product
 Table 51. Eurofins Discovery Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 52. Eurofins Discovery Recent Development
 Table 53. Charles River Laboratories Company Details
 Table 54. Charles River Laboratories Business Overview
 Table 55. Charles River Laboratories High-Throughput Screening Services for Drug Discovery Product
 Table 56. Charles River Laboratories Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 57. Charles River Laboratories Recent Development
 Table 58. Axcelead Company Details
 Table 59. Axcelead Business Overview
 Table 60. Axcelead High-Throughput Screening Services for Drug Discovery Product
 Table 61. Axcelead Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 62. Axcelead Recent Development
 Table 63. NUVISAN Company Details
 Table 64. NUVISAN Business Overview
 Table 65. NUVISAN High-Throughput Screening Services for Drug Discovery Product
 Table 66. NUVISAN Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 67. NUVISAN Recent Development
 Table 68. Axxam S.p.A. Company Details
 Table 69. Axxam S.p.A. Business Overview
 Table 70. Axxam S.p.A. High-Throughput Screening Services for Drug Discovery Product
 Table 71. Axxam S.p.A. Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 72. Axxam S.p.A. Recent Development
 Table 73. Evotec Company Details
 Table 74. Evotec Business Overview
 Table 75. Evotec High-Throughput Screening Services for Drug Discovery Product
 Table 76. Evotec Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 77. Evotec Recent Development
 Table 78. Selvita Company Details
 Table 79. Selvita Business Overview
 Table 80. Selvita High-Throughput Screening Services for Drug Discovery Product
 Table 81. Selvita Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 82. Selvita Recent Development
 Table 83. Azenta Life Sciences Company Details
 Table 84. Azenta Life Sciences Business Overview
 Table 85. Azenta Life Sciences High-Throughput Screening Services for Drug Discovery Product
 Table 86. Azenta Life Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 87. Azenta Life Sciences Recent Development
 Table 88. Bienta (Enamine) Company Details
 Table 89. Bienta (Enamine) Business Overview
 Table 90. Bienta (Enamine) High-Throughput Screening Services for Drug Discovery Product
 Table 91. Bienta (Enamine) Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 92. Bienta (Enamine) Recent Development
 Table 93. Cayman Chemical Company Details
 Table 94. Cayman Chemical Business Overview
 Table 95. Cayman Chemical High-Throughput Screening Services for Drug Discovery Product
 Table 96. Cayman Chemical Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 97. Cayman Chemical Recent Development
 Table 98. Creative Biolabs Company Details
 Table 99. Creative Biolabs Business Overview
 Table 100. Creative Biolabs High-Throughput Screening Services for Drug Discovery Product
 Table 101. Creative Biolabs Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 102. Creative Biolabs Recent Development
 Table 103. Creative Bioarray Company Details
 Table 104. Creative Bioarray Business Overview
 Table 105. Creative Bioarray High-Throughput Screening Services for Drug Discovery Product
 Table 106. Creative Bioarray Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 107. Creative Bioarray Recent Development
 Table 108. BOC Sciences Company Details
 Table 109. BOC Sciences Business Overview
 Table 110. BOC Sciences High-Throughput Screening Services for Drug Discovery Product
 Table 111. BOC Sciences Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 112. BOC Sciences Recent Development
 Table 113. MEDICILON Company Details
 Table 114. MEDICILON Business Overview
 Table 115. MEDICILON High-Throughput Screening Services for Drug Discovery Product
 Table 116. MEDICILON Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 117. MEDICILON Recent Development
 Table 118. Domainex Company Details
 Table 119. Domainex Business Overview
 Table 120. Domainex High-Throughput Screening Services for Drug Discovery Product
 Table 121. Domainex Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 122. Domainex Recent Development
 Table 123. Creative Diagnostics Company Details
 Table 124. Creative Diagnostics Business Overview
 Table 125. Creative Diagnostics High-Throughput Screening Services for Drug Discovery Product
 Table 126. Creative Diagnostics Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 127. Creative Diagnostics Recent Development
 Table 128. Multispan Company Details
 Table 129. Multispan Business Overview
 Table 130. Multispan High-Throughput Screening Services for Drug Discovery Product
 Table 131. Multispan Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 132. Multispan Recent Development
 Table 133. AntalGenics Company Details
 Table 134. AntalGenics Business Overview
 Table 135. AntalGenics High-Throughput Screening Services for Drug Discovery Product
 Table 136. AntalGenics Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 137. AntalGenics Recent Development
 Table 138. Creative Biostructure Company Details
 Table 139. Creative Biostructure Business Overview
 Table 140. Creative Biostructure High-Throughput Screening Services for Drug Discovery Product
 Table 141. Creative Biostructure Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 142. Creative Biostructure Recent Development
 Table 143. BPS Bioscience Company Details
 Table 144. BPS Bioscience Business Overview
 Table 145. BPS Bioscience High-Throughput Screening Services for Drug Discovery Product
 Table 146. BPS Bioscience Revenue in High-Throughput Screening Services for Drug Discovery Business (US$ Million), 2021–2026
 Table 147. BPS Bioscience Recent Development
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. High-Throughput Screening Services for Drug Discovery Picture
 Figure 2. Global High-Throughput Screening Services for Drug Discovery Market Size Comparison by Type (US$ Million), 2021–2032
 Figure 3. Global High-Throughput Screening Services for Drug Discovery Market Share by Type: 2025 vs 2032
 Figure 4. Chemical-based HTS Assays Features
 Figure 5. Biological-based HTS Assays Features
 Figure 6. Cell-based HTS Assays Features
 Figure 7. Genetic-based HTS Assays Features
 Figure 8. Global High-Throughput Screening Services for Drug Discovery Market Size by Application (US$ Million), 2021–2032
 Figure 9. Global High-Throughput Screening Services for Drug Discovery Market Share by Application: 2025 vs 2032
 Figure 10. Pharmaceutical Company Case Studies
 Figure 11. Biotechnology Company Case Studies
 Figure 12. High-Throughput Screening Services for Drug Discovery Report Years Considered
 Figure 13. Global High-Throughput Screening Services for Drug Discovery Market Size (US$ Million), Year-over-Year: 2021–2032
 Figure 14. Global High-Throughput Screening Services for Drug Discovery Market Size, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global High-Throughput Screening Services for Drug Discovery Market Share by Region: 2025 vs 2032
 Figure 16. Global High-Throughput Screening Services for Drug Discovery Market Share by Players in 2025
 Figure 17. Global High-Throughput Screening Services for Drug Discovery Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
 Figure 18. The Top 10 and 5 Players Market Share by High-Throughput Screening Services for Drug Discovery Revenue in 2025
 Figure 19. North America High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 20. North America High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
 Figure 21. United States High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 22. Canada High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 23. Europe High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 24. Europe High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
 Figure 25. Germany High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 26. France High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 27. U.K. High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 28. Italy High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 29. Russia High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 30. Ireland High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 31. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 32. Asia-Pacific High-Throughput Screening Services for Drug Discovery Market Share by Region (2021–2032)
 Figure 33. China High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 34. Japan High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 35. South Korea High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 36. Southeast Asia High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 37. India High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 38. Australia & New Zealand High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 39. Latin America High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 40. Latin America High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
 Figure 41. Mexico High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 42. Brazil High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 43. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 44. Middle East & Africa High-Throughput Screening Services for Drug Discovery Market Share by Country (2021–2032)
 Figure 45. Israel High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 46. Saudi Arabia High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 47. UAE High-Throughput Screening Services for Drug Discovery Market Size YoY Growth (US$ Million), 2021–2032
 Figure 48. Eurofins Discovery Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 49. Charles River Laboratories Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 50. Axcelead Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 51. NUVISAN Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 52. Axxam S.p.A. Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 53. Evotec Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 54. Selvita Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 55. Azenta Life Sciences Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 56. Bienta (Enamine) Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 57. Cayman Chemical Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 58. Creative Biolabs Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 59. Creative Bioarray Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 60. BOC Sciences Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 61. MEDICILON Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 62. Domainex Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 63. Creative Diagnostics Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 64. Multispan Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 65. AntalGenics Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 66. Creative Biostructure Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 67. BPS Bioscience Revenue Growth Rate in High-Throughput Screening Services for Drug Discovery Business (2021–2026)
 Figure 68. Bottom-up and Top-down Approaches for This Report
 Figure 69. Data Triangulation
 Figure 70. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS